Terms: = Ovarian cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217 AND Treatment
3 results:
1. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer.
Carvalho RF; do Canto LM; Abildgaard C; Aagaard MM; Tronhjem MS; Waldstrøm M; Jensen LH; Steffensen KD; Rogatto SR
Cell Commun Signal; 2022 Nov; 20(1):176. PubMed ID: 36352420
[TBL] [Abstract] [Full Text] [Related]
2. Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis.
Ponandai-Srinivasan S; Saare M; Boggavarapu NR; Frisendahl C; Ehrström S; Riethmüller C; García-Uribe PA; Rettkowski J; Iyengar A; Salumets A; Lalitkumar PGL; Götte M; Gemzell-Danielsson K
Hum Reprod; 2020 Oct; 35(10):2280-2293. PubMed ID: 32897364
[TBL] [Abstract] [Full Text] [Related]
3. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
